European Commission approves labelling update for REYATAZ® (atazanavir sulfate) in pregnant women living with HIV
Bristol-Myers Squibb Company today announced that the European Commission approved a labelling update for REYATAZ based on new data generated in pregnant women living with HIV.
LONDON, Sept. 23, 2010-The European Medicines Agency today recommended the suspension of the marketing authorisations for the rosiglitazone-containing anti-diabetes medicines Avandia, Avandamet and Avaglim.